Qualitative imaging features, such as frontal lobe tumor location, homogeneous signal intensity, sparse contrast enhancement within the tumor beds, and less intensive tumor infiltration are some of the imaging signatures that have been used to identify IDH-mutant gliomas with variable success [49,50,51]. Here, IDH1 is linked to central nervous system cancer.